Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
September 2, 2016
Viral Engineering of Chimeric Antigen Receptor Expression on Murine and Human T Lymphocytes
Joanne A Hammill, Arya Afsahi, Jonathan L Bramson, et al.
Molecular Therapy Oncolytics
|
April 28, 2016
Chimeric antigen receptor-engineered T cells as oncolytic virus carriers
Heather VanSeggelen, Daniela Gm Tantalo, Arya Afsahi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 28, 2018
CD11b<sup>+</sup> Dendritic Cell-Mediated Anti-<i>Mycobacterium tuberculosis</i> Th1 Activation Is Counterregulated by CD103<sup>+</sup> Dendritic Cells via IL-10
Rocky Lai, Mangalakumari Jeyanathan, Sam Afkhami, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 22, 2011
Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines
Jennifer D Bassett, Stephanie L Swift, Heather VanSeggelen, et al.
Journal for Immunotherapy of Cancer
|
December 18, 2015
Designed ankyrin repeat proteins are effective targeting elements for chimeric antigen receptors
Joanne A Hammill, Heather VanSeggelen, Christopher W Helsen, et al.
Oncoimmunology
|
November 15, 2021
Manufacturing T cells in hollow fiber membrane bioreactors changes their programming and enhances their potency
Seung Mi Yoo, Vivan W C Lau, Craig Aarts, et al.
Oncoimmunology
|
February 28, 2025
Humanized mouse models of <i>KRAS</i>-mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies
Maria E Davola, Olga Cormier, Madeleine Lepard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 1, 2015
T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice
Heather VanSeggelen, Joanne A Hammill, Anna Dvorkin-Gheva, et al.
Molecular Therapy. Oncology
|
July 24, 2024
Electrophilic proximity-inducing synthetic adapters enhance universal T cell function by covalently enforcing immune receptor signaling
Nickolas J Serniuck, Eden Kapcan, Duane Moogk, et al.
Iscience
|
April 9, 2025
DAP12-associated synthetic antigen receptors enable multi-targeting of T cells with independent chimeric receptors in a small genetic payload
Allyson E Moore, Hayley Nault, Derek Cummings, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
September 2, 2016
Viral Engineering of Chimeric Antigen Receptor Expression on Murine and Human T Lymphocytes
Joanne A Hammill, Arya Afsahi, Jonathan L Bramson, et al.
Molecular Therapy Oncolytics
|
April 28, 2016
Chimeric antigen receptor-engineered T cells as oncolytic virus carriers
Heather VanSeggelen, Daniela Gm Tantalo, Arya Afsahi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 28, 2018
CD11b<sup>+</sup> Dendritic Cell-Mediated Anti-<i>Mycobacterium tuberculosis</i> Th1 Activation Is Counterregulated by CD103<sup>+</sup> Dendritic Cells via IL-10
Rocky Lai, Mangalakumari Jeyanathan, Sam Afkhami, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 22, 2011
Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines
Jennifer D Bassett, Stephanie L Swift, Heather VanSeggelen, et al.
Journal for Immunotherapy of Cancer
|
December 18, 2015
Designed ankyrin repeat proteins are effective targeting elements for chimeric antigen receptors
Joanne A Hammill, Heather VanSeggelen, Christopher W Helsen, et al.
Oncoimmunology
|
November 15, 2021
Manufacturing T cells in hollow fiber membrane bioreactors changes their programming and enhances their potency
Seung Mi Yoo, Vivan W C Lau, Craig Aarts, et al.
Oncoimmunology
|
February 28, 2025
Humanized mouse models of <i>KRAS</i>-mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies
Maria E Davola, Olga Cormier, Madeleine Lepard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 1, 2015
T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice
Heather VanSeggelen, Joanne A Hammill, Anna Dvorkin-Gheva, et al.
Molecular Therapy. Oncology
|
July 24, 2024
Electrophilic proximity-inducing synthetic adapters enhance universal T cell function by covalently enforcing immune receptor signaling
Nickolas J Serniuck, Eden Kapcan, Duane Moogk, et al.
Iscience
|
April 9, 2025
DAP12-associated synthetic antigen receptors enable multi-targeting of T cells with independent chimeric receptors in a small genetic payload
Allyson E Moore, Hayley Nault, Derek Cummings, et al.
Page
of 2